{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:46:13Z","timestamp":1759693573792,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cpcardiol.2024.102451","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T19:04:28Z","timestamp":1707591868000},"page":"102451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and efficacy of antithrombotics in outpatients with symptomatic COVID-19: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"given":"Saad Ali","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooraldin","family":"Merza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2964-9452","authenticated-orcid":false,"given":"Adarsh","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra Zafar","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsah Alim Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunaina","family":"Bhimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afrah Saeed","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unaiza","family":"Naqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areeba","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simra","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Feroze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishaque","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2022","series-title":"Weekly Epidemiological Update on COVID-19","key":"10.1016\/j.cpcardiol.2024.102451_bib0001"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0002","doi-asserted-by":"crossref","first-page":"e26371","DOI":"10.1097\/MD.0000000000026371","article-title":"Mild to moderate COVID-19 illness in adult outpatients: characteristics, symptoms, and outcomes in the first 4 weeks of illness","volume":"100","author":"Blair","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0003","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1152\/physrev.00035.2020","article-title":"Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets","volume":"101","author":"Sriram","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0004","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1093\/cid\/ciab813","article-title":"Randomized study of Rivaroxaban vs Placebo on disease progression and symptoms resolution in high-risk adults with mild coronavirus disease 2019","volume":"75","author":"Ananworanich","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0005","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s10067-020-05275-1","article-title":"Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad","volume":"39","author":"Ahmed","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00133-20","article-title":"Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): a systemic infection","volume":"34","author":"Synowiec","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0007","first-page":"1","article-title":"Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials","author":"Ena","year":"2022","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2022.09.001","article-title":"Anticoagulation in COVID-19 patients \u2013 An updated systematic review and meta-analysis","volume":"219","author":"Reis","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-021-00343-1","article-title":"Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis","volume":"19","author":"Zhang","year":"2021","journal-title":"Thromb J"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0010","first-page":"190","article-title":"Parenteral and oral anticoagulant treatment for hospitalized and post-discharge COVID-19 patients: a systematic review and meta-analysis","volume":"54","author":"Tunjungputri","year":"2022","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0011","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11239-022-02681-x","article-title":"Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials","volume":"54","author":"Pilia","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0012","article-title":"Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis","author":"Wills","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0013","article-title":"Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial","volume":"376","author":"Bikdeli","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0014","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: The PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0015","unstructured":"RoB 2: a revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias. [cited 2022 Nov 22]. Available from: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials."},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0019","first-page":"94","article-title":"Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial","volume":"121","author":"Gonzalez-Ochoa","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0018","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0017","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(22)00175-2","article-title":"Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"9","author":"Barco","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0025","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1093\/cid\/ciab813","article-title":"Randomized study of Rivaroxaban vs Placebo on disease progression and symptoms resolution in high-risk adults with mild Coronavirus disease 2019","volume":"75","author":"Ananworanich","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0016","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2352-3026(22)00173-9","article-title":"Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial","volume":"9","author":"Cools","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2022.09.001","article-title":"Anticoagulation in COVID-19 patients \u2013 An updated systematic review and meta-analysis","volume":"219","author":"Reis","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2020.08.020","article-title":"Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis","volume":"196","author":"Porfidia","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0021","doi-asserted-by":"crossref","unstructured":"Thachil J, Tang N, Gando | Satoshi, Falanga A, Cattaneo M, Levi M, et al. Recommendations and guidelines ISTH interim guidance on recognition and management of coagulopathy in COVID-19. 2020 [cited 2022 Nov 22]; Available from: https:\/\/orcid.org\/0000-0002-3525-0750.","DOI":"10.1111\/jth.14810"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620937175","article-title":"C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis","volume":"14","author":"Huang","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0026","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11239-022-02681-x","article-title":"Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials","volume":"54","author":"Pilia","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0027","first-page":"677","article-title":"Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Ortega-Paz","year":"2022","journal-title":"Eur Hear J"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac285","article-title":"Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Coronavirus disease 2019: a systematic review and meta-analysis","volume":"9","author":"Wills","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cpcardiol.2024.102451_bib0030","article-title":"Thrombosis after covid-19 vaccination","volume":"373","author":"Hunter","year":"2021","journal-title":"BMJ"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:53:21Z","timestamp":1758941601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0146280624000902"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102451","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of antithrombotics in outpatients with symptomatic COVID-19: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102451"}}